Anand V Kulkarni
Overview
Explore the profile of Anand V Kulkarni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
113
Citations
806
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumar A, Teng M, Kulkarni A
Aliment Pharmacol Ther
. 2025 Mar;
61(7):1238-1239.
PMID: 40084839
No abstract available.
2.
Kulkarni A, Kumar K, Giri S, Arab J, Venishetty S, Premkumar M, et al.
Am J Gastroenterol
. 2025 Mar;
PMID: 40079479
Objectives: Current guidance recommends a 40-mg dose of prednisolone (or equivalent) for severe alcohol-associated hepatitis (AAH), while infections are not uncommon in them. The benefits of a rapid prednisolone tapering...
3.
Patidar K, Ma A, Juanola A, Barone A, Incicco S, Kulkarni A, et al.
Lancet Gastroenterol Hepatol
. 2025 Mar;
PMID: 40058397
Background: Acute kidney injury (AKI) is a serious complication of cirrhosis. A systematic, global characterisation of AKI occurring in patients with cirrhosis is lacking. We therefore aimed to assess global...
4.
Moeckli B, Wassmer C, El Hajji S, Kumar R, Rodrigues Ribeiro J, Tabrizian P, et al.
Hepatology
. 2025 Mar;
PMID: 40042053
Background Aims: Immune checkpoint inhibitors (ICI) are increasingly used in patients with advanced hepatocellular carcinoma (HCC) patients awaiting liver transplantation (LT). However, concerns about the risk of post-transplant rejection persist....
5.
Choudhury A, Kulkarni A, Arora V, Soin A, Dokmeci A, Chowdhury A, et al.
Hepatol Int
. 2025 Feb;
19(1):1-69.
PMID: 39961976
Acute-on-chronic liver failure (ACLF) is a condition associated with high mortality in the absence of liver transplantation. There have been various definitions proposed worldwide. The first consensus report of the...
6.
Roy A, Mehtani R, Kulkarni A
Gastro Hep Adv
. 2025 Feb;
4(3):100583.
PMID: 39911499
No abstract available.
7.
Amara V, Kulkarni A, Gupta A, Venishetty S, Sripathi S, Reddy L, et al.
Indian J Crit Care Med
. 2025 Jan;
28(11):1015-1022.
PMID: 39882056
Aim And Background: A combination of terlipressin and albumin is the standard of care for patients with hepatorenal syndrome-acute kidney injury (HRS-AKI). The study aimed to compare the venous congestion...
8.
Premkumar M, Bhujade H, Sharma P, Nain J, Ahluwalia J, Sandhu A, et al.
Aliment Pharmacol Ther
. 2025 Jan;
61(6):971-987.
PMID: 39748673
Background And Aims: We assessed clinical, procoagulant and genetic risk factors and clinical outcomes in dabigatran-treated patients with non-tumoural acute and acute-on-chronic portal vein thrombosis (PVT). Methods: Patients with a...
9.
Kanneganti M, Al-Hasan M, Bourque S, Deodhar S, Yang J, Huang D, et al.
Clin Gastroenterol Hepatol
. 2024 Nov;
PMID: 39571877
Background & Aims: Age and comorbidity are key factors in assessing patient prognosis and informing stopping rules for cancer screening eligibility, but their impact has not been rigorously evaluated in...
10.
Kulkarni A, Venishetty S, Kumar K, Gurav N, Albhaisi S, Chhabbra P, et al.
Intern Med J
. 2024 Oct;
55(1):109-116.
PMID: 39462915
Background And Aims: Severity scores, including the model for end-stage liver disease (MELD) and discriminant function score, guide the treatment of patients with severe alcohol-associated hepatitis (AH). We aimed to...